We read with great interest the recent letter sent to you by McConnell and colleagues [1] , in which they discuss one of the first applications of truly independent home-based electrical brain stimulation, applied following safety recommendations. Transcranial direct-current stimulation (tDCS) is a non-invasive brain stimulation technique capable of modulating cortical excitability beyond the stimulation period [2, 3] . tDCS presents interesting options as a therapeutic intervention in multiple neurological disorders, such as stroke, depression, chronic pain, schizophrenia, and Alzheimer's and Parkinson's diseases [4, 5] . The effects of this technique can accumulate over multiple stimulation sessions [6] , but visiting specialized centers to regularly receive such an intervention presents practical issues (e.g., travel time and costs) that limit access to these benefits. Portable, inexpensive devices for tDCS are available on the market, making them an attractive option for home-based stimulation, an approach that has been gaining momentum in the past decade [7] . Nevertheless, readily-availability of this technology allows its irresponsible use [8] , which poses safety hazards for users and threatens to demerit the potential of this tool for therapeutic applications.
Dear Editor,
We read with great interest the recent letter sent to you by McConnell and colleagues [1] , in which they discuss one of the first applications of truly independent home-based electrical brain stimulation, applied following safety recommendations. Transcranial direct-current stimulation (tDCS) is a non-invasive brain stimulation technique capable of modulating cortical excitability beyond the stimulation period [2, 3] . tDCS presents interesting options as a therapeutic intervention in multiple neurological disorders, such as stroke, depression, chronic pain, schizophrenia, and Alzheimer's and Parkinson's diseases [4, 5] . The effects of this technique can accumulate over multiple stimulation sessions [6] , but visiting specialized centers to regularly receive such an intervention presents practical issues (e.g., travel time and costs) that limit access to these benefits. Portable, inexpensive devices for tDCS are available on the market, making them an attractive option for home-based stimulation, an approach that has been gaining momentum in the past decade [7] . Nevertheless, readily-availability of this technology allows its irresponsible use [8] , which poses safety hazards for users and threatens to demerit the potential of this tool for therapeutic applications.
Even though there have been first studies concerning tDCS applied at home [7] , few of them have required users to apply stimulation by themselves, as there are multiple parameters to control for stimulation to be effective. Nevertheless, seeking to provide home-based tDCS therapeutically calls for the users' independent application, such that it might be unconstrained by availability of specialized personnel. We are currently conducting a study involving the remotely-controlled, unsupervised self-application of home-based tDCS during the execution of a motor training. Participants train two different tasks with their left hand (i.e. a sequencetapping task (Fig.1B) and a visuo-motor task (Fig. 1C) ) for two weeks each, while receiving anodal electrical stimulation over the hand representation in the right motor cortex according to safety recommendations [9] . In total, participants receive 400 minutes of tDCS over the course of 20 days (five consecutive days per week). So far, five healthy participants (2 women, 64 ± 7.3 yr., range 51e68 yr.) have completed training. Participants gave their informed consent under protocol guidelines approved by the cantonal ethics committee Vaud, Switzerland (project No.2017-00301), according to the Declaration of Helsinki. We do the first session in the lab to teach the participants how to use the setup, and we give them a detailed manual including illustrations with every step of the training preparation and execution for later consultation. We use a Neuroelectrics Star-Stim8 device to deliver stimulation, and the Neuroelectrics-Instrument-Controller to remotely control stimulation parameters (stimulation duration, amplitude, dosage, etc.) and monitor stimulation progress. Participants wear a cap with electrodes attached to fixed locations (left-supraorbital and C4, 10e20 system, Fig. 1A) . Our training task is performed on a tablet and can only start once the stimulation is active; the software transmits all generated training data to our server right after its completion.
Participant acceptance was very high. All participants felt comfortable setting up the stimulation and training by the end of the first week. They described training as interesting and even fun, valuing the relative gamification of our tasks. An intruding factor, pointed out by some participants, was the sporadic loss of concentration at home due to external interruptions (e.g. dog barking, neighbor ringing doorbell, etc.).
Participants were scheduled to contact us at the end of each week for a debriefing session. We found this contact to be very important in keeping participants engaged, giving relevance to their efforts, and showing we cared about their well-being. This is a crucial aspect to consider when providing similar services to patients, as having less-frequent contact with healthcare specialists due to receiving self-applied home-based therapies could affect their motivation.
Use of our proposed setup was not equally simple for all participants. Within the group, younger participants (especially those still working) had no problems self-applying the intervention together with its respective training. Older participants, less familiar with computers, struggled slightly during the first couple of days, requiring telephonic assistance for troubleshooting more often. We strived to reduce preparation steps as much as possible to minimize mistakes, providing a minimum amount of equipment parts and simplifying the interface. Participant adhesion was 90.1 ± 4.1%, affected mostly by malfunction of the stimulation software (i.e. the server managing stimulation sessions went down and remained so for three days). This constitutes a single-point-of-failure to the setup and might be critical for therapeutic interventions.
Another lesson we learned was the importance of assistance and support around the clock. Users having difficulties when setting up stimulation or training can face a large degree of frustration (this happened to one of our participants), which is why someone should be available for questions and support at all times, especially for patients. Technical issues may arise anytime, but their prompt solution is paramount to avoid therapy interruptions or mistrust towards the system. There were no adverse events reported over the whole month of training, other than slight tingling at the start of the stimulation.
When used correctly, tDCS is a powerful tool to modulate cortical plasticity, which can be applied to enhance motor learning, as well as to treat a variety of neurological conditions, including post-stroke recovery. Periodic self-application at home shows promise as a cost-effective, personalized therapeutic intervention allowing high training intensities, but it requires continuous monitoring of multiple parameters to ensure a responsible, safe, and effective usage of this technology. We have identified various important aspects to control in order to provide a reliable service to patients. A simple, user-friendly setup is of the utmost importance, and troubleshooting assistance should be available at all times to avoid frustration or mistrust towards the system. This system should be robust and tech support should be provided immediately in case of malfunction. Future work should address important technical details, like the optimal placement of stimulation electrodes for a particular condition. Our group is working on an automated tracking system to help users place electrodes as consistently as possible across days, which might help reduce variability in the effects of stimulation [10] .
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The authors declare that they have no competing interests. 11 wearing a cap punctured at FP1 and C4, restricting electrode placement to these locations. Electrodes were 5 cm in diameter, soaked with 10 ml of saline solution each, applied with a syringe. B) Sequence-tapping task, requiring participants to replicate a motor sequence as fast and as accurately as possible using a numerical pad. C) Visuo-motor task, requiring participants to follow a shape on the touch-screen using a stylus, as fast and as accurately as possible.
